Physician profile
Jonathan Yu
NPI 1518345362
$1,236.70
in general payments reported to CMS, 2019-2025
11 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.15 · 2020: $84.81 · 2021: $193 · 2022: $201 · 2023: $14.50 · 2024: $306 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $409.38 | 2020-2025 | Evos, Trigen Intertan |
| Stryker Corporation | $176.30 | 2025 | Pangea, Variax |
| Depuy Synthes Sales INC. | $156.76 | 2021-2022 | |
| Prime Surgical, LLC | $156.15 | 2024 | |
| Medical Device Business Services, INC. | $109.65 | 2022 | |
| Exsomed Corporation | $69.67 | 2019 | |
| Omnilife Science, INC | $58.24 | 2020 | |
| Axogen | $40.69 | 2021 | |
| Bioventus LLC | $32.03 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Medtronic USA, INC. | $16.48 | 2019 | |
| Endo Pharmaceuticals INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.